BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24051970)

  • 1. [Unidentified bright objects and neuropsychiatric disturbances].
    Bassi B; Vannelli S; Giraudo MC; Burdino E; Rigardetto R
    Minerva Pediatr; 2013 Aug; 65(4):371-81. PubMed ID: 24051970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unidentified bright objects in neurofibromatosis type 1: conventional MRI in the follow-up and correlation of microstructural lesions on diffusion tensor images.
    Ferraz-Filho JR; José da Rocha A; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Eur J Paediatr Neurol; 2012 Jan; 16(1):42-7. PubMed ID: 22088602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Managing children with neurofibromatosis type 1: what should we look for?].
    Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
    Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood.
    Chabernaud C; Sirinelli D; Barbier C; Cottier JP; Sembely C; Giraudeau B; Deseille-Turlotte G; Lorette G; Barthez MA; Castelnau P
    Dev Neuropsychol; 2009; 34(6):736-48. PubMed ID: 20183730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children.
    DeBella K; Poskitt K; Szudek J; Friedman JM
    Neurology; 2000 Apr; 54(8):1646-51. PubMed ID: 10762507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis type 1: diffusion weighted imaging findings of brain.
    Alkan A; Sigirci A; Kutlu R; Ozcan H; Erdem G; Aslan M; Ates O; Yakinci C; Egri M
    Eur J Radiol; 2005 Nov; 56(2):229-34. PubMed ID: 15963674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1.
    Lopes Ferraz Filho JR; Munis MP; Soares Souza A; Sanches RA; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Pediatr Radiol; 2008 Mar; 38(3):305-10. PubMed ID: 18231788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using a semi-automated approach to quantify Unidentified Bright Objects in Neurofibromatosis type 1 and linkages to cognitive and academic outcomes.
    Harriott EM; Nguyen TQ; Landman BA; Barquero LA; Cutting LE
    Magn Reson Imaging; 2023 May; 98():17-25. PubMed ID: 36608909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurofibromatosis type 1 in children. Experiences of the Gdansk Paediatric Oncohaematology Centre. Preliminary results].
    Sierota D; Stefanowicz J; Wierzba J; Adamkiewicz-Drozyńska E; Wybieralska-Dubaniewicz M; Kosiak W; Komasara L; Czauderna P; Izycka-Swieszewska E; Pilarska E; Birkholtz D; Stachowicz-Stencel T; Połczyńska K; Bień E; Szołkiewicz A; Stefanowicz A; Balcerska A
    Med Wieku Rozwoj; 2007; 11(3 Pt 2):307-12. PubMed ID: 18663272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of unidentified bright objects in the neurocognitive profile of neurofibromatosis type 1 children: a volumetric MRI analysis.
    Di Stasi M; Cocozza S; Buccino S; Paolella C; Di Napoli L; D'Amico A; Melis D; Ugga L; Villano G; Ruocco M; Scala I; Brunetti A; Elefante A
    Acta Neurol Belg; 2024 Feb; 124(1):223-230. PubMed ID: 37733157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse pontine lesions in children with neurofibromatosis type 1: making a case for unidentified bright objects.
    Hervey-Jumper SL; Singla N; Gebarski SS; Robertson P; Maher CO
    Pediatr Neurosurg; 2013; 49(1):55-9. PubMed ID: 24192157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological profile in Italian children with neurofibromatosis type 1 (NF1) and their relationships with neuroradiological data: Preliminary results.
    Parmeggiani A; Boiani F; Capponi S; Duca M; Angotti M; Pignataro V; Sacrato L; Spinardi L; Vara G; Maltoni L; Cecconi I; Pastore Trossello M; Franzoni E
    Eur J Paediatr Neurol; 2018 Sep; 22(5):822-830. PubMed ID: 29802023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T2-weighted hyperintensities (unidentified bright objects) in children with neurofibromatosis 1: their impact on cognitive function.
    Goh WH; Khong PL; Leung CS; Wong VC
    J Child Neurol; 2004 Nov; 19(11):853-8. PubMed ID: 15658789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the detectability of UBOs in Neurofibromatosis Type I patients with proton density-weighted and FLAIR sequences in 3T MRI.
    Tritt S; Hillenbrand N; Liesirova K; Moein G; Kieslich M; Porto L
    Eur J Paediatr Neurol; 2018 Jul; 22(4):615-619. PubMed ID: 29610060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of MRI T2 hyperintensities and cognitive functioning in patients with neurofibromatosis type 1.
    Feldmann R; Schuierer G; Wessel A; Neveling N; Weglage J
    Acta Paediatr; 2010 Nov; 99(11):1657-60. PubMed ID: 21039823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1.
    Tognini G; Ferrozzi F; Garlaschi G; Piazza P; Patti A; Virdis R; Bertolino C; Bertolino G; Manfredini D; Zompatori M; Crisi G
    J Comput Assist Tomogr; 2005; 29(3):298-304. PubMed ID: 15891494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial MR imaging and 1H-MR spectroscopy of unidentified bright objects in a case of neurofibromatosis type 1.
    Imamura A; Matsuo N; Okuda M; Morita H; Iwata M; Yamazaki Y; Takahashi Y
    Brain Dev; 2005 Dec; 27(8):595-7. PubMed ID: 15878248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1.
    Denckla MB; Hofman K; Mazzocco MM; Melhem E; Reiss AL; Bryan RN; Harris EL; Lee J; Cox CS; Schuerholz LJ
    Am J Med Genet; 1996 Feb; 67(1):98-102. PubMed ID: 8678124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Natural evolution of neurocutaneous syndrome in adults].
    Pou Serradell A
    Rev Neurol; 1996 Sep; 24(133):1085-127. PubMed ID: 8755348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.